Cancer diagnostics News and Research

RSS

Detroit paper explores pain of facing breast cancer without insurance

A woman with a $7,000 annual income and $67 in the bank was diagnosed with breast cancer, leading to a week of phone calls from her surgeon to state, federal and hospital officials before a charitable agreement was struck with a medical center, the Detroit Free Press reports.

12 Jan 2010

National survey reveals many Canadians understand risk of colon cancer, but are not taking action

A new national survey reveals that while almost all Canadians understand the importance of getting checked for colon cancer, most have not had a screening test and are confused about how and when it should happen.

8 Jan 2010

OncoDiagnostic Laboratory acquired by Predictive Biosciences

Predictive Biosciences today announced that it has acquired Cleveland, Ohio based OncoDiagnostic Laboratory (“ODL”), a private, Clinical Laboratory Improvement Act (CLIA)-certified anatomic pathology and molecular diagnostics lab serving urologists, gastroenterologists, dermatologists, gynecologists, and other subspecialty physicians nationwide.

7 Jan 2010

Response Genetics and Genetic Technologies sign exclusive distribution and services agreement

Response Genetics Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, and Genetic Technologies Ltd. (ASX: GTG; NASDAQ: GENE), the leading private genetic testing laboratory in Australia, today announced an exclusive distribution and services agreement.

7 Jan 2010

Protective benefits of Alzheimer's and cancer may lead to new diagnostic treatments

People who have Alzheimer's disease may be less likely to develop cancer, and people who have cancer may be less likely to develop Alzheimer's disease, according to a new study published in the December 23, 2009, online issue of Neurology®, the medical journal of the American Academy of Neurology.

23 Dec 2009

Arrayit achieves technological breakthrough in microarray production

Arrayit Corporation, a life sciences and healthcare technology leader, today announced that the Company has made a technological breakthrough in the speed and efficiency by which it manufactures its proprietary microarrays, which are tiny glass substrates that contain rows and columns of printed spots used for scientific research and molecular diagnostics.

22 Dec 2009

Clarient announces acquisition of Applied Genomics

Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it has acquired privately held, Huntsville, AL-based Applied Genomics, Inc. (AGI) in an all-stock merger valued at up to $17.6 million, if all conditions and milestones set forth in the merger agreement are successfully met.

21 Dec 2009

Rosetta Genomics announces third-quarter 2009 financial results

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported financial results for the three and nine months ended September 30, 2009 and provided a business update.

18 Dec 2009

Four commonly used chemotherapy drugs disrupt birth of new brain cells, shows study

Researchers have developed a novel animal model showing that four commonly used chemotherapy drugs disrupt the birth of new brain cells, and that the condition could be partially reversed with the growth factor IGF-1.

18 Dec 2009

FDA clears Agendia's MammaPrint breast cancer recurrence test for all ages

Agendia, a world leader in molecular cancer diagnostics, announced today that the US Food and Drug Administration (FDA) cleared its MammaPrint breast cancer recurrence test for all ages. MammaPrint is the only FDA-cleared breast cancer recurrence test available to patients and physicians.

17 Dec 2009

Human MicroRNA Panel for gene-expression profiling to be launched by WaferGen Biosystems

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genetic analysis systems, today announced that it will be launching the Human MicroRNA Panel for its innovative service for gene-expression profiling using its SmartChip(TM) Real-Time PCR System.

17 Dec 2009

ChromoCure's new Southeast Research Center to be based in Aventura, Florida

ChromoCure, Inc. announced today its new Southeast Research Center to be based in Aventura, Florida.

17 Dec 2009

Scientists rediscover Cyclin G1 gene as prime target for anti-cancer therapies

Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, gained international validation of the cutting-edge science behind its lead oncology product, Rexin-G, when scientists around the world rediscovered the Cyclin G1 gene to be a major locus of cancer pathogenesis and disease progression, and thus a prime target for anti-cancer therapies.

16 Dec 2009

Increased physical activity decreases risk of colorectal cancer

Increased physical activity appears to be associated with a lower risk of cancer-specific and overall death in men with a history of colorectal cancer that has not spread to other parts of the body, according to a report in the December 14/28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

15 Dec 2009

Soyfood consumption linked to decreased risk of breast cancer, finds study

A major new study published in the Journal of the American Medical Association (JAMA) finds that women with breast cancer would be well-served by including soyfoods in their daily diet. Soyfood consumption was significantly linked to a decreased risk of death and cancer recurrence among the breast cancer patients in this study.

11 Dec 2009

Biomoda, Christiana Care Health System partner in study of CyPath lung cancer diagnostic test

Cancer diagnostics company Biomoda, Inc. today announced that The Helen F. Graham Cancer Center associated with Christiana Care Health System, a screening site for the International Early Lung Cancer Program (I-ELCAP), will recruit a cohort of patients diagnosed with lung cancer to participate in the final stage of the Phase II pilot study of the investigational CyPath® assay, an early-stage diagnostic test for lung cancer.

10 Dec 2009

Event proceeds to benefit Virginia G. Piper Cancer Center at Scottsdale Healthcare

Scottsdale Healthcare Foundation announced today that Daniel Von Hoff, MD will be Honoree at its 34th annual Honor Ball. Dr. Von Hoff, an oncologist and chief scientific officer at Scottsdale Healthcare's Virginia G. Piper Cancer Center, is known worldwide for his groundbreaking cancer research.

10 Dec 2009

Arrayit Diagnostics signs exclusive License Agreement with Wayne State University

Arrayit Diagnostics, Inc., a majority-owned subsidiary of Arrayit Corporation (OTC Bulletin Board: ARYC), today announced that it has signed an exclusive License Agreement with Wayne State University to key intellectual property covering discoveries of biomarkers of ovarian cancer.

10 Dec 2009

Soy food beneficial for women with breast cancer

Although there is a concern regarding the safety of soy food consumption among breast cancer survivors, researchers have found that women in China who had breast cancer and a higher intake of soy food had an associated lower risk of death and breast cancer recurrence, according to a study in the December 9 issue of JAMA.

9 Dec 2009

Soy food associated with lower risk of death and breast cancer recurrence, says new study

Researchers at Vanderbilt-Ingram Cancer Center, led by Xiao Ou Shu, M.D., Ph.D., professor of Medicine, have found that a higher intake of soy foods was associated with a lower risk of death and breast cancer recurrence among breast cancer patients in China. The study is published in the December 9 issue of JAMA.

9 Dec 2009

Cancer diagnostics News and Research

Detroit paper explores pain of facing breast cancer without insurance

National survey reveals many Canadians understand risk of colon cancer, but are not taking action

OncoDiagnostic Laboratory acquired by Predictive Biosciences

Response Genetics and Genetic Technologies sign exclusive distribution and services agreement

Protective benefits of Alzheimer's and cancer may lead to new diagnostic treatments

Arrayit achieves technological breakthrough in microarray production

Clarient announces acquisition of Applied Genomics

Rosetta Genomics announces third-quarter 2009 financial results

Four commonly used chemotherapy drugs disrupt birth of new brain cells, shows study

FDA clears Agendia's MammaPrint breast cancer recurrence test for all ages

Human MicroRNA Panel for gene-expression profiling to be launched by WaferGen Biosystems

ChromoCure's new Southeast Research Center to be based in Aventura, Florida

Scientists rediscover Cyclin G1 gene as prime target for anti-cancer therapies

Increased physical activity decreases risk of colorectal cancer

Soyfood consumption linked to decreased risk of breast cancer, finds study

Biomoda, Christiana Care Health System partner in study of CyPath lung cancer diagnostic test

Event proceeds to benefit Virginia G. Piper Cancer Center at Scottsdale Healthcare

Arrayit Diagnostics signs exclusive License Agreement with Wayne State University

Soy food beneficial for women with breast cancer

Soy food associated with lower risk of death and breast cancer recurrence, says new study

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News